Bridgeway Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,496	Closed	-$605K	–	1347
2019 Q2	$605K	Sell	8,496 -801	-9%	-$57K	0.01%	915
2019 Q1	$729K	Buy	+9,297	New	+$729K	0.01%	876